HIGHLIGHTS
- who: Luisa Schumacher et al. from the Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany have published the research work: Efficacy and Tolerance of IMRT Boost Compared to IORT Boost in Early Breast Cancer: A German Monocenter Study, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of 15/Dec/2022
- what: The aim of this retrospective study is to compare the two boost subgroups IORT or IMRT in terms of overall survival (OS) progression-free survival (PFS) cosmesis and acute and late toxicity. In this study, due to the lack of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.